Renewal of Novo Nordisk Pharmaceuticals’ cGMP certificate
The Danish Medicines Agency has recently renewed its cGMP certificate in accordance with EU GMP Part II (ICH Q7) for an additional three-year period.
Novo Nordisk Pharmaceuticals is the world-leading manufacturer of quaternary ammonium compounds.
Our cGMP manufactured pharmaceutical grade products, such as Benzalkonium Chloride, Cetrimide, Strong Cetrimide, MKC and CTAB, are in full compliance with ICH’s guide Q7 for API and are analysed according to Ph.Eur., BP, USP/NF and JP. We also offer access to CEP and DMF.
Visit our team of experts at CphI 2013 in Frankfurt at stand 62B48 in Hall 6.2 to discuss your specific requirements.